Volume 22, Issue 4, 2023
Meet the Frontier Section Editor
Pp: 461-461
Author(s): Nady Braidy
DOI: 10.2174/187152732204230116112705
Published on: 16 January, 2023
Rethinking Catatonia: New Insights from the Autism Spectrum
Pp: 462-465
Author(s): Liliana Dell’Osso, Daniela Toschi, Giulia Amatori* and Camilla Gesi
DOI: 10.2174/1871527321666220406105844
Published on: 15 June, 2022
Natural Products as Bioactive Agents in the Prevention of Dementia
Pp: 466-476
Author(s): Hamid Ullah, Abrar Hussain, Muhammad Asif, Faheem Nawaz and Mahmood Rasool*
DOI: 10.2174/1871527321666220422085835
Published on: 13 July, 2022
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease
Pp: 477-499
Author(s): Farhan Mazahir and Awesh K. Yadav*
DOI: 10.2174/1871527321666220420133059
Published on: 06 July, 2022
Importance of Pharmacophore in Designing Anticonvulsant Agents
Pp: 500-511
Author(s): Amol Kale*, Rajendra Kakde, Smita Pawar, Vishal Jagtap and Rahul Dorugade
DOI: 10.2174/1871527321666220401115529
Published on: 21 July, 2022
Inter/Transgenerational Effects of Drugs of Abuse: A Scoping Review
Pp: 512-538
Author(s): Mitra-Sadat Sadat-Shirazi, Mahsa Sadeghi-Adl, Ardeshir Akbarabadi, Ghorbangol Ashabi, Azarakhsh Mokri and Mohammad-Reza Zarrindast*
DOI: 10.2174/1871527321666220429122819
Published on: 14 June, 2022
Dopaminergic Signaling as a Plausible Modulator of Astrocytic Toll-Like Receptor 4: A Crosstalk between Neuroinflammation and Cognition
Pp: 539-557
Author(s): Prasada Chowdari Gurram, Suman Manandhar, Sairaj Satarker, Jayesh Mudgal, Devinder Arora and Madhavan Nampoothiri*
DOI: 10.2174/1871527321666220413090541
Published on: 14 June, 2022
Dopamine as a Potential Target for Learning and Memory: Contributing to Related Neurological Disorders
Pp: 558-576
Author(s): Masoumeh Kourosh-Arami*, Alireza Komaki and Mohammad-Reza Zarrindast
DOI: 10.2174/1871527321666220418115503
Published on: 15 June, 2022
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease
Pp: 577-598
Author(s): Yi Wang*
DOI: 10.2174/1871527321666220417005115
Published on: 10 June, 2022
Characteristics of Amphetamine Psychosis with Respect to the Length of Drug Exposure
Pp: 599-606
Author(s): Anastasia Babina, Iryna Sokolova* and Mykhailo Vysotskyi
DOI: 10.2174/1871527321666220726141936
Published on: 29 August, 2022
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis
Pp: 607-613
Author(s): Hongning Jia*, Xiaoyuan Qi, Huijun Wu and Jianping Wang
DOI: 10.2174/1871527321666220329144538
Published on: 17 June, 2022
Treatment of Major Depression with Psychotic Features and Cotard’s Syndrome after COVID-19 Infection in a Previously Healthy Patient: A Case Report
Pp: 614-617
Author(s): Hasan Mervan Aytac*
DOI: 10.2174/1871527321666220516110620
Published on: 25 August, 2022
Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine
Pp: 618-621
Author(s): Ismail Rammouz*, Jalal Doufik, Rachid Aalouane and Saïd Boujraf
DOI: 10.2174/1871527321666220829112733
Published on: 16 September, 2022
